(MedPage Today) — Patients with noninfectious or posterior uveitis had significant improvement with a single intravitreal dexamethasone implant, results of a sham-control trial showed.
Richard L. Abbott, MD Begins Term As President Of American Academy Of Ophthalmology
Richard L. Abbott, MD became the new president of the American Academy of Ophthalmology on January 1, 2011, taking over from departing President Randy Johnston, MD. Dr. Abbott currently serves as the Thomas W. Boyden health sciences clinical professor …
Top Eye Specialist For PSA’s Offshore Refresher Conference, Australia
Leading eye specialist Dr Peter van Wijngaarden will be one of the faculty of expert speakers at the 2011 PSA Offshore Refresher Conference this year. Dr Peter van Wijngaarden, who was one of the most popular presenters at PAC10 in Melbourne last year…
Lucentis(R) (Ranibizumab) Launched For Vision Loss Due To Diabetic Macular Oedema, A Serious And Common Complication Of Diabetes
Novartis Pharmaceuticals UK Ltd announced that Lucentis® (ranibizumab) has launched in the UK for the treatment of visual impairment due to diabetes, specifically diabetic macular oedema (DMO). This offers fresh hope for people with this serious and c…
EyeSense Attracts QIAGEN As Strategic Investor
Strategic Partnership to Develop and Commercialize a Novel Ophthalmic Self-Diagnostic System for Blood Glucose Monitoring by Diabetes Patients
Ifa Systems acquires inoveon
ifa Systems AG, the global leader for IT solutions in ophthalmology based in Cologne, Germany, announced the acquisition of inoveon Corporation, proven experts in detection, staging, and monitoring of diabetic retinopathy and macular edema.